Jane Street Group, LLC Spectrum Pharmaceuticals Inc Put Options Transaction History

Jane Street Group, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$0.63 - $1.59 $44,793 - $113,049	-71,100 Reduced 85.35%	12,200 $16,000
Q4 2021 Feb 15, 2022	BUY	$1.27 - $2.42 $87,757 - $167,222	69,100 Added 486.62%	83,300 $106,000
Q3 2021 Nov 16, 2021	SELL	$2.15 - $3.82 $22,360 - $39,728	-10,400 Reduced 42.28%	14,200 $31,000
Q2 2021 Aug 16, 2021	SELL	$2.89 - $4.45 $253,164 - $389,820	-87,600 Reduced 78.07%	24,600 $92,000
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $392,700 - $1.16 Million	112,200 New	112,200 $408,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.